ATE239751T1 - 9-hydrazon- und 9-azynerythromycinderivate und verfahren zu deren herstellung - Google Patents

9-hydrazon- und 9-azynerythromycinderivate und verfahren zu deren herstellung

Info

Publication number
ATE239751T1
ATE239751T1 AT98944641T AT98944641T ATE239751T1 AT E239751 T1 ATE239751 T1 AT E239751T1 AT 98944641 T AT98944641 T AT 98944641T AT 98944641 T AT98944641 T AT 98944641T AT E239751 T1 ATE239751 T1 AT E239751T1
Authority
AT
Austria
Prior art keywords
hydrazone
derivatives
azynerythromycine
production
erythromycin
Prior art date
Application number
AT98944641T
Other languages
English (en)
Inventor
David R Hill
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE239751T1 publication Critical patent/ATE239751T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid Thermionic Cathode (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98944641T 1997-09-10 1998-09-01 9-hydrazon- und 9-azynerythromycinderivate und verfahren zu deren herstellung ATE239751T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/927,057 US5929219A (en) 1997-09-10 1997-09-10 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
PCT/US1998/018115 WO1999012946A1 (en) 1997-09-10 1998-09-01 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same

Publications (1)

Publication Number Publication Date
ATE239751T1 true ATE239751T1 (de) 2003-05-15

Family

ID=25454102

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98944641T ATE239751T1 (de) 1997-09-10 1998-09-01 9-hydrazon- und 9-azynerythromycinderivate und verfahren zu deren herstellung

Country Status (13)

Country Link
US (2) US5929219A (de)
EP (1) EP1015466B1 (de)
JP (1) JP2001515914A (de)
KR (1) KR100553468B1 (de)
AT (1) ATE239751T1 (de)
AU (1) AU9213698A (de)
CA (1) CA2301639C (de)
DE (1) DE69814422T2 (de)
DK (1) DK1015466T3 (de)
ES (1) ES2198745T3 (de)
IL (2) IL134468A0 (de)
PT (1) PT1015466E (de)
WO (1) WO1999012946A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL124084A0 (en) * 1998-04-14 1999-04-11 Chemagis Ltd Erythromycin a derivatives and methods for the preparation thereof
IL125372A0 (en) * 1998-07-15 1999-03-12 Chemagis Ltd Erythromycin derivatives and methods for the preparation thereof
KR100317907B1 (ko) * 1998-11-24 2001-12-24 김 완 주 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
CA2401571A1 (en) * 2000-02-29 2001-09-07 Ilya Avrutov Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
US6605707B1 (en) 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
EP1648415A4 (de) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
WO2005009368A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005023184A2 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1771158A4 (de) 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp Tablette für pulsierte abgabe
FI117133B (fi) 2004-10-19 2006-06-30 Auramo Oy Menetelmä ja pihtilaite kuormien käsittelemiseksi
ES2261090B1 (es) * 2005-04-25 2007-06-16 Ercros Industrial, S.A. Procedimiento de obtencion de derivados de eritromicina a y compuestos obtenidos.
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
RU2455308C2 (ru) * 2006-05-01 2012-07-10 Тайсо Фармасьютикал Ко., Лтд. Макролидные производные
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin
CN102382157B (zh) * 2010-09-03 2015-04-08 上海医药工业研究院 一种红霉素a衍生物及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759252A (fr) 1969-11-21 1971-05-21 Lilly Co Eli Erytromycyl b amine
GB1344629A (en) 1970-09-30 1974-01-23 Lilly Industries Ltd Erythromycin azine derivatives
US3869444A (en) 1972-10-10 1975-03-04 Abbott Lab Esters of erythromycin oxime
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
US4336368A (en) 1981-04-20 1982-06-22 Pfizer Inc. 4 Deoxy-4-methylene oleandomycin and derivatives thereof
JPS5896095A (ja) 1981-11-30 1983-06-07 Taisho Pharmaceut Co Ltd １１−ｏ−アルキルエリスロマイシンａ誘導体
JPS5896097A (ja) 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS5896098A (ja) 1981-12-03 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
US4526889A (en) 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
GR860655B (en) 1985-03-12 1986-07-11 Beecham Group Plc Chemical compounds
GB8506380D0 (en) 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
US4640910A (en) 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
JPS63107994A (ja) 1986-05-02 1988-05-12 Taisho Pharmaceut Co Ltd エリスロマイシン誘導体
US4740502A (en) 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
GB8721165D0 (en) * 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5302705A (en) 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives

Also Published As

Publication number Publication date
EP1015466A1 (de) 2000-07-05
CA2301639A1 (en) 1999-03-18
ES2198745T3 (es) 2004-02-01
IL134468A (en) 2009-09-01
JP2001515914A (ja) 2001-09-25
WO1999012946A1 (en) 1999-03-18
USRE39531E1 (en) 2007-03-27
IL134468A0 (en) 2001-04-30
CA2301639C (en) 2007-06-26
DE69814422D1 (de) 2003-06-12
AU9213698A (en) 1999-03-29
KR100553468B1 (ko) 2006-02-22
EP1015466B1 (de) 2003-05-07
DE69814422T2 (de) 2004-05-06
PT1015466E (pt) 2003-09-30
KR20010023778A (ko) 2001-03-26
US5929219A (en) 1999-07-27
DK1015466T3 (da) 2003-09-01

Similar Documents

Publication Publication Date Title
ATE239751T1 (de) 9-hydrazon- und 9-azynerythromycinderivate und verfahren zu deren herstellung
DE59713056D1 (de) Wellenlängenkonvertierende Vergussmasse, deren Verwendung und Verfahren zu deren Herstellung
DE69812489D1 (de) Korrosionsbeständiges Bauteil, Waferträger und Verfahren zu deren Herstellung
DE69815126D1 (de) Pyrimidinderivate und verfahren zu deren herstellung
DE69827319D1 (de) Solarzelle und Verfahren zu deren Herstellung
DE69611524D1 (de) Alkalische cellulase und verfahren zu deren herstellung
DE69705222D1 (de) Gitteranordnung und verfahren zu deren herstellung
DE59710363D1 (de) Trägereinlage, Verfahren zu deren Herstellung und deren Verwendung
DE69608403D1 (de) Elektronenemittierende elektrode und verfahren zu deren herstellung
DE69721399D1 (de) Verfahren für die herstellung von zementplatten
DE69616516D1 (de) Wasserschutzzusammensetzungen und verfahren zu deren herstellung
ATE279506T1 (de) Tabletten und verfahren zu deren herstellung
DE69829063D1 (de) Polymer, verfahren zu dessen herstellung und härtbare zusammensetzung, die dieses polymer enthält
DE69608359D1 (de) Hexaazaisowurtzitan-derivate und verfahren zu deren herstellung
DE59608456D1 (de) Photodiode und verfahren zu deren herstellung
DE69527220D1 (de) Verbesserte Dachbahn und Verfahren zu dessen Herstellung
DE59705614D1 (de) Trägereinlage, Verfahren zu deren Herstellung und deren Verwendung
DE69633873D1 (de) Alkalische cellulase und verfahren zu deren herstellung
DE69700952D1 (de) Zusammensetzungen für bodenbehandlung, verfahren zu deren herstellung und verwendung
DE69610481D1 (de) Prostaglandine und verfahren zu deren herstellung
DE69841905D1 (de) Photovernetzbare folie,daraus hergestellte formmassen und verfahren zu deren herstellung
FI974435A7 (fi) Menetelmä 2,4-diklooripyridiinien muuttamiseksi 2-aryylioksi-4-kloorip yridiineiksi
DE69605443D1 (de) Umweltverträgliche, wässrige mullit-sole, mullit-zusammensetzungen und verfahren zu deren herstellung
ATE231910T1 (de) Verdickte bleichmittelzusammensetzungen, gebrauchsverfahren und verfahren zu deren herstellung
DE3781192D1 (de) Mikroorganismus, esterase und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1015466

Country of ref document: EP

REN Ceased due to non-payment of the annual fee